Okuyama Y - Search Results

1

In vitro melanin binding of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist.

Yamada T, Okuyama Y, Mukai H. Yamada T, et al. Among authors: okuyama y. Arzneimittelforschung. 2001;51(4):299-303. doi: 10.1055/s-0031-1300041. Arzneimittelforschung. 2001. PMID: 11367870

2

Pharmacokinetics of prulifloxacin. 3rd communication: metabolism in rats, dogs and monkeys.

Okuyama Y, Morino A. Okuyama Y, et al. Arzneimittelforschung. 1997 Mar;47(3):293-8. Arzneimittelforschung. 1997. PMID: 9105548

3

Pharmacokinetics of prulifloxacin. 2nd communication: pharmacokinetics and effect on hepatic drug-metabolizing enzyme activities after repeated administration and transfer into fetus and milk after a single administration in rats.

Okuyama Y, Momota K, Morino A. Okuyama Y, et al. Arzneimittelforschung. 1997 Mar;47(3):285-92. Arzneimittelforschung. 1997. PMID: 9105547

4

Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.

Okuyama Y, Momota K, Morino A. Okuyama Y, et al. Arzneimittelforschung. 1997 Mar;47(3):276-84. Arzneimittelforschung. 1997. PMID: 9105546

5

Paraoxonase has a major role in the hydrolysis of prulifloxacin (NM441), a prodrug of a new antibacterial agent.

Tougou K, Nakamura A, Watanabe S, Okuyama Y, Morino A. Tougou K, et al. Among authors: okuyama y. Drug Metab Dispos. 1998 Apr;26(4):355-9. Drug Metab Dispos. 1998. PMID: 9531524

6

Pharmacokinetics and safety of NM441, a new quinolone, in healthy male volunteers.

Nakashima M, Uematsu T, Kosuge K, Okuyama Y, Morino A, Ozaki M, Takebe Y. Nakashima M, et al. Among authors: okuyama y. J Clin Pharmacol. 1994 Sep;34(9):930-7. doi: 10.1002/j.1552-4604.1994.tb04007.x. J Clin Pharmacol. 1994. PMID: 7983237 Clinical Trial.

7

Metabolism of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate in rats, guinea pigs, dogs and monkeys.

Sugiyama M, Ando T, Okuyama Y, Sugimoto T, Choukai S. Sugiyama M, et al. Among authors: okuyama y. Arzneimittelforschung. 1986 Aug;36(8):1229-36. Arzneimittelforschung. 1986. PMID: 3778560

8

[Studies on the metabolism of 4'-chloro-5-methoxy-3-biphenylylacetic acid (DKA-9) in rat and the anti-inflammatory activity of DKA-9 and its metabolites (author's transl)].

Sugiyama M, Okuyama Y, Yoshimoto Y. Sugiyama M, et al. Among authors: okuyama y. Yakugaku Zasshi. 1978 Jan;98(1):31-40. doi: 10.1248/yakushi1947.98.1_31. Yakugaku Zasshi. 1978. PMID: 641699 Japanese. No abstract available.

9

[Studies on the metabolism of 4'-chloro-5-methoxy-3-biphenylylacetic acid (DKA-9) in human and various animal species (author's transl)].

Sugiyama M, Tatewaki N, Sugimoto T, Okuyama Y, Nakagawa T. Sugiyama M, et al. Among authors: okuyama y. Yakugaku Zasshi. 1978 Mar;98(3):302-11. doi: 10.1248/yakushi1947.98.3_302. Yakugaku Zasshi. 1978. PMID: 418166 Japanese. No abstract available.

10

Bmi1 Regulates IκBα Degradation via Association with the SCF Complex.

Okuyama Y, Tanaka Y, Jiang JJ, Kamimura D, Nakamura A, Ota M, Ohki T, Higo D, Ogura H, Ishii N, Atsumi T, Murakami M. Okuyama Y, et al. J Immunol. 2018 Oct 15;201(8):2264-2272. doi: 10.4049/jimmunol.1701223. Epub 2018 Sep 12. J Immunol. 2018. PMID: 30209188

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

476 results

Search Page

Filters